08045804946
Send Inquiry
GLENZA 40MG CAPS
1600.0 INR/Vial
Product Details:
- Origin of Medicine India
- Brand Name GLENZA
- Salt Composition Enzalutamide 40mg
- Indication Metastatic castration-resistant prostate cancer (mCRPC)
- Packaging Type Blister pack/Box
- Life Span 24 months from date of manufacture
- Dosage Form Oral
- Click to View more
X
GLENZA 40MG CAPS Price And Quantity
- 1 Number
- 1600.0 INR/Vial
- Oral administration
- Not recommended for use in women
- For use under medical supervision only
- 2 years from the date of manufacture
- Approved
- Yes
- Fatigue, back pain, hot flushes, hypertension, headache, dizziness
- Prescription-only (Rx)
- Oncology
GLENZA 40MG CAPS Product Specifications
- 40 mg per capsule, as directed by physician
- Adults, mainly male patients with prostate cancer
- Blister pack/Box
- Enzalutamide
- 28 capsules per box
- Store below 30C, protect from moisture
- Capsule
- Treatment of prostate cancer
- Oral
- 24 months from date of manufacture
- Take orally as per doctors recommendation
- 1 strip (number of capsules may vary)
- India
- GLENZA
- Enzalutamide 40mg
- Metastatic castration-resistant prostate cancer (mCRPC)
- Antineoplastic agent (anti-cancer)
- Men
- Oral administration
- Not recommended for use in women
- For use under medical supervision only
- 2 years from the date of manufacture
- Approved
- Yes
- Fatigue, back pain, hot flushes, hypertension, headache, dizziness
- Prescription-only (Rx)
- Oncology
GLENZA 40MG CAPS Trade Information
- Cash in Advance (CID), Cash on Delivery (COD), Cash Advance (CA)
- 1000 Number Per Week
- 2 Days
- No
- South America, Eastern Europe, Asia, Australia, Central America, North America, Western Europe, Middle East, Africa
- All India
Product Description
Glenza 40mg is prescribed to treat various stages of prostate cancer:
- Metastatic castration-resistant prostate cancer (mCRPC): Cancer that has spread to other body parts and no longer responds to treatments that lower testosterone.
- Non-metastatic castration-resistant prostate cancer (nmCRPC): Cancer that has not visibly spread but is no longer responding to hormone-lowering treatments.
- Metastatic hormone-sensitive prostate cancer: Used in combination with other hormone therapy when the cancer has spread but still responds to hormone-lowering treatments.
In some cases, it may also be used to manage symptoms of Polycystic Ovarian Syndrome (PCOS) or excessive hair growth in women, as determined by a doctor.
How It Works
Prostate cancer cells often rely on male hormones (androgens), such as testosterone and dihydrotestosterone (DHT), to grow and multiply. Enzalutamide works by blocking the androgen receptors in these cancer cells. This action prevents the male hormones from binding to the receptors and signaling the cancer cells to grow, effectively slowing the cancer's progression or causing the tumor to shrink.
Powerful Anti-Cancer Therapy for Prostate Cancer
GLENZA 40MG CAPS provide targeted therapy for men suffering from metastatic castration-resistant prostate cancer (mCRPC). This advanced formulation works by inhibiting androgen receptors, thereby slowing cancer progression. With a trusted approval status, GLENZA offers hope and effective treatment under the diligent supervision of medical professionals.
Recommended Usage and Administration
Intended for adult male patients, GLENZA capsules are taken orally as directed by your physician. It is crucial to follow the prescribed dosage-typically one 40mg capsule at a time-without missing doses. Usage outside medical guidance is not recommended, and regular monitoring ensures optimal therapeutic outcomes and manages any potential side effects.
Safe Storage and Longevity Assured
Ensuring the longevity of GLENZA, capsules should be stored below 30C and away from moisture. Each strip and box is clearly labeled with manufacturing and expiry dates, granting a 24-month lifespan from the date of production. This protects both efficacy and safety throughout the treatment duration.
FAQ's of GLENZA 40MG CAPS:
Q: What is GLENZA 40MG CAPS used for?
A: GLENZA 40MG CAPS is used for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult male patients. It is an antineoplastic medicine that helps slow the progression of prostate cancer.Q: How should I take GLENZA 40MG CAPS?
A: You should take GLENZA 40MG CAPS orally as prescribed by your physician. The usual dosage is one capsule (40mg) per administration, and dosing frequency should be as directed by your healthcare provider. Do not alter the dose or stop treatment without consulting your doctor.Q: When should GLENZA 40MG CAPS be administered?
A: GLENZA should be administered at the same time each day, as per your doctor's advice. Maintaining a consistent schedule helps maximize therapeutic benefits and supports effective treatment monitoring.Q: Where should GLENZA 40MG CAPS be stored?
A: Store GLENZA capsules below 30C in a dry place, away from moisture and direct sunlight. Keep the medication in its original blister pack or box to ensure proper protection and stability.Q: What are the possible side effects of GLENZA?
A: Common side effects include fatigue, back pain, hot flushes, increased blood pressure (hypertension), headache, and dizziness. Inform your doctor if you experience any of these or other unexpected symptoms during treatment.Q: Who should not use GLENZA 40MG CAPS?
A: GLENZA 40MG CAPS is not recommended for use in women, especially during pregnancy, or in children. It is intended strictly for adult males diagnosed with prostate cancer under medical supervision.Q: What are the benefits of taking GLENZA for prostate cancer?
A: GLENZA provides a targeted approach for men with advanced prostate cancer, helping slow disease progression and improving quality of life when taken as part of a comprehensive treatment plan overseen by a healthcare professional.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
